Resistin concentrations in murine adipose tissue and serum measured by a new enzyme immunoassay (Q38314661)

2 September 2017

title

Resistin concentrations in murine adipose tissue and serum measured by a new enzyme immunoassay (English)

1 reference

2 September 2017

Aya Fujinami

1

1 reference

2 September 2017

Kiyoe Ohta

2

1 reference

2 September 2017

Hidehito Matsui

3

1 reference

2 September 2017

Naoko Kitada

4

1 reference

2 September 2017

Yuko Kitaura

5

1 reference

2 September 2017

Yuji Kawahara

6

1 reference

2 September 2017

Hiroshi Obayashi

7

1 reference

2 September 2017

Sadako Kuno

8

1 reference

2 September 2017

Naoto Nakamura

9

1 reference

2 September 2017

Mitsuhiro Ohta

10

1 reference

2 September 2017

publication date

1 February 2006

1 reference

2 September 2017

1 reference

2 September 2017

volume

14

1 reference

2 September 2017

issue

2

1 reference

2 September 2017

page(s)

199-205

1 reference

New perspectives into the molecular pathogenesis and treatment of type 2 diabetes

2 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.26

Obesity in the new millennium

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.26

Transcriptional regulation of gene expression during adipocyte differentiation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.26

Obesity and the regulation of energy balance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.26

Banting lecture 1988. Role of insulin resistance in human disease

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.26

The hormone resistin links obesity to diabetes

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.26

Adipose tissue resistin expression is severely suppressed in obesity and stimulated by peroxisome proliferator-activated receptor gamma agonists

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.26

Decreased Resistin Expression in Mice with Different Sensitivities to a High-Fat Diet

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.26

Visceral adipose tissue impairs insulin secretion and insulin sensitivity but not energy expenditure in obesity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.26

Obesity and insulin resistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.26

Removal of visceral fat prevents insulin resistance and glucose intolerance of aging: an adipokine-mediated process?

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.26

Surgical removal of visceral fat reverses hepatic insulin resistance.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.26

Relationship of generalized and regional adiposity to insulin sensitivity in men with NIDDM

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.26

Distribution of adipose tissue and risk of cardiovascular disease and death: a 12 year follow up of participants in the population study of women in Gothenburg, Sweden.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.26

Resistin, central obesity, and type 2 diabetes.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.26

Human resistin gene: molecular scanning and evaluation of association with insulin sensitivity and type 2 diabetes in Caucasians

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.26

Humoral regulation of resistin expression in 3T3-L1 and mouse adipose cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.26

Increased resistin expression in the adipose tissue of male prolactin transgenic mice and in male mice with elevated androgen levels

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.26

A cysteine-rich adipose tissue-specific secretory factor inhibits adipocyte differentiation

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.26

Resistin and adiponectin expression in visceral fat of obese rats: effect of weight loss.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.26

Regulation of resistin expression and circulating levels in obesity, diabetes, and fasting

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.26

Changes in glycemia by leptin administration or high- fat feeding in rodent models of obesity/type 2 diabetes suggest a link between resistin expression and control of glucose homeostasis

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.26

Regulation of fasted blood glucose by resistin

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.26

Adipose expression of tumor necrosis factor-alpha: direct role in obesity-linked insulin resistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.26

Increased adipose tissue expression of tumor necrosis factor-alpha in human obesity and insulin resistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.26

Tumor necrosis factor-alpha-induced insulin resistance in 3T3-L1 adipocytes is accompanied by a loss of insulin receptor substrate-1 and GLUT4 expression without a loss of insulin receptor-mediated signal transduction.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.26

Tumor necrosis factor-alpha acutely inhibits insulin signaling in human adipocytes: implication of the p80 tumor necrosis factor receptor.

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.26

Tumor necrosis factor alpha: a key component of the obesity-diabetes link

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.26

The role of TNFalpha and TNF receptors in obesity and insulin resistance

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.26

TNF-alpha-induced insulin resistance in vivo and its prevention by troglitazone

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FOBY.2006.26

31 March 2020

Identifiers

DOI

10.1038/OBY.2006.26

1 reference

release_p3zjttezfreexkvebkc3e3mrpa

2 September 2017

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/p3zjttezfreexkvebkc3e3mrpa

mapped directly with Wikidata item

24 November 2022

based on heuristic

1 reference